Edition:
United States

Natus Medical Inc (BABY.OQ)

BABY.OQ on NASDAQ Stock Exchange Global Select Market

38.55USD
4:00pm EDT
Change (% chg)

$0.45 (+1.18%)
Prev Close
$38.10
Open
$38.20
Day's High
$38.80
Day's Low
$38.05
Volume
42,436
Avg. Vol
106,058
52-wk High
$44.39
52-wk Low
$29.54

Latest Key Developments (Source: Significant Developments)

Natus Medical sees Q1 2017 revenue $122 mln to $124 mln
Monday, 9 Jan 2017 07:00am EST 

Natus Medical Inc ; : Natus Medical announces 2017 annual and first quarter financial guidance . Sees Q1 2017 non-gaap earnings per share $0.32 to $0.34 . Sees FY 2017 non-gaap earnings per share $1.80 to $1.85 . Sees Q1 2017 revenue $122 million to $124 million . Sees Q4 2016 revenue about $107.5 million to $108 million . Sees FY 2017 revenue $505 million to $510 million . Q4 earnings per share view $0.53, revenue view $107.6 million -- Thomson Reuters I/B/E/S . Q1 earnings per share view $0.43, revenue view $104.9 million -- Thomson Reuters I/B/E/S .FY2016 earnings per share view $1.64, revenue view $381.8 million -- Thomson Reuters I/B/E/S.  Full Article

Natus Medical CEO James Hawkins reports open market purchase of 10,000 shares
Wednesday, 28 Sep 2016 10:43am EDT 

Natus Medical Inc :Ceo james hawkins reports open market purchase of 10,000 shares of co's common stock at average price of $38.5 on september 28 - sec filing.  Full Article

Natus medical sees Q3 2016 revenue $89 mln to $91 mln
Monday, 26 Sep 2016 07:00am EDT 

Natus Medical Inc : Sees Q3 2016 revenue $89 million to $91 million . Natus enters into agreement to acquire gn otometrics; provides Q3 revenue update . Updated its Q3 2016 revenue guidance to $89 million to $91 million compared to previous guidance of $97 million to $98 million . Majority of expected Q3 revenue shortfall is due to voluntary ship hold co placed on certain products produced in seattle facility . Expect Otometrics to be accretive to 2017 earnings with a NON-GAAP contribution operating margin goal for year of 10%, 2018 goal of 20% . Remaining Q3 revenue shortfall is primarily due to lower demand in international markets . Updates q3 revenue guidance . Expects acquisition to be immediately accretive to NON-GAAP earnings . Deal for $145 million . Natus will use offshore cash and proceeds from this credit line to fund acquisition . Natus medical inc says has entered into a $150 million revolving credit agreement with JP Morgan Chase, n.a. And Citibank, n.a . Says with addition of Otometrics, anticipate Natus revenue in 2017 will reach $500 million .Q3 revenue view $97.8 million -- Thomson Reuters I/B/E/S.  Full Article

Natus Medical Q2 non-gaap earnings per share $0.39
Wednesday, 20 Jul 2016 06:10am EDT 

Natus Medical Inc Says Q2 Non : Q2 gaap earnings per share $0.32 . For q3 2016, company expects revenue of $97.0 million to $98.0 million . Sees Q3 2016 non-gaap earnings per share $0.41 to $0.43 . Sees Q3 2016 gaap earnings per share $0.35 to $0.37 . Gaap gross profit margin was 60.5% versus. 63.2% reported for Q2 of 2015 . Sees FY 2016 non-gaap earnings per share $1.67 to $1.70 . FY2016 earnings per share view $1.66, revenue view $386.9 million -- Thomson Reuters I/B/E/S . Q2 non-gaap earnings per share $0.39 . Q2 revenue rose 4.5 percent to $96 million . Increased its full year 2016 revenue guidance and now expects revenue of $388 million to $390 million . Sees FY 2016 gaap earnings per share $1.35 to $1.38 . Q2 earnings per share view $0.36, revenue view $92.7 million -- Thomson Reuters I/B/E/S .Q3 earnings per share view $0.44, revenue view $100.2 million -- Thomson Reuters I/B/E/S.  Full Article

Natus Medical acquires Retcam Ophthalmic Imaging System
Wednesday, 6 Jul 2016 07:00am EDT 

Natus Medical Inc : Deal for $10.6 million . Expect deal to be immediately accretive to 2016 earnings .Natus medical acquires Retcam Ophthalmic Imaging System.  Full Article

Natus Medical to repurchase up to an additional $20 mln shares - SEC filing
Friday, 3 Jun 2016 06:34am EDT 

Natus Medical Inc : Board of directors has approved an expansion of its existing stock repurchase program; expiration date is set for June 1, 2017 . Board authorizing repurchase of up to an additional $20 million of company's common stock - SEC filing .To use cash on hand, cash generated from operations, existing credit facilities or other financing to fund share repurchase program.  Full Article

Natus Medical Inc says acquisition of assets of NeuroQuest LLC
Thursday, 3 Mar 2016 08:42am EST 

Natus Medical Inc:Says acquisition of assets of NeuroQuest LLC.Says expect acquisition to add approximately $2.5 million in additional revenue during 2016 and to be immediately accretive to earnings.  Full Article

Natus Medical Inc gives FY, Q1 2016 outlook; updates Q4, FY 2015 revenue outlook
Monday, 11 Jan 2016 06:58am EST 

Natus Medical Inc:Expects FY 2016 revenue of $445 million to $450 million and non-GAAP earnings per share of $1.84 to $1.88.Expects Q1 2016, revenue of $96.5 million to $97.5 million and non-GAAP earnings per share of $0.34 to $0.35.Expects to report revenue of about $100.0 million for Q4 2015, compared to prior guidance of $102.0 million to $105.0 million and FY 2015 revenue of $375.9 million compared to prior guidance of $378.0 million to $381.0 million.  Full Article

Natus Medical Inc increases FY 2015 non-GAAP earnings guidance; GivesQ3 2015 guidance
Wednesday, 22 Jul 2015 06:00am EDT 

Natus Medical Inc:Sees Q3 2015 revenue of $93.0 million to $94.0 million.Sees Q3 2015 non-GAAP earnings per share of $0.37 to $0.38.Says it has increased its non-GAAP earnings guidance for FY 2015.Sees FY 2015 non-GAAP earnings per share of $1.50 to $1.52, an increase from previous guidance of $1.47 to $1.51.Sees FY 2015 revenue guidance was unchanged at $376 million to $378 million.  Full Article

Natus Medical announces $20 mln share repurchase program
Friday, 5 Jun 2015 07:00am EDT 

Natus Medical Inc:Has approved an expansion of its existing stock repurchase program, authorizing the repurchase of up to an additional $20 mln of the Company's common stock.There is no set expiration date for the program.In June 2014, the Company announced the adoption of a share repurchase program for the repurchase of up to $10 million of the Company's common stock, which the Company expects to complete by June 30.Company intends to use cash on hand, cash generated from operations, existing credit facilities or other financing to fund the share repurchase program.As of March 31, the Company had cash and cash equivalents of about $67 mln and availability under an existing line of credit of $25 million.  Full Article

More From Around the Web

BRIEF-Natus Medical reports Q4 GAAP earnings per share $0.31

* Natus Medical announces fourth quarter and full year 2016 financial results